The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells

The clinical success of chimeric antigen receptor (CAR) T cell immunotherapy in the treatment of haematological cancers has encouraged the extensive development of CAR design to improve their function and increase their applicability. Advancements in protein engineering have seen modifications to bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes-Parry, Hannah E., Cross, Ryan S., Jenkins, Misty R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981602/
https://www.ncbi.nlm.nih.gov/pubmed/31892219
http://dx.doi.org/10.3390/ijms21010204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981602/
https://www.ncbi.nlm.nih.gov/pubmed/31892219
http://dx.doi.org/10.3390/ijms21010204

Ejemplares similares